Publications by authors named "Catherine Maes"

Claim this Profile
R
Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine.
Isabel Leroux-Roels, Gwenn Waerlop, Jessika Tourneur, Fien De Boever, Catherine Maes

Front Immunolยท April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis